H.E.P.A.R (Hepatic Ensemble Predictive Analysis Resource): A Convergent Machine Learning Architecture for Drug-Induced Liver Injury Prediction
ISEF · 2026 Computational Biology and Bioinformatics
Overview
Drug-induced liver injury (DILI) accounts for 13% of acute toxicity cases in the U.S. and remains a primary barrier to pharmaceutical development. While most machine learning models predict DILI via chemical structure alone, few utilize bimodal approaches incorporating biological indicators. This study introduces HEPAR (Hepatotoxic Ensemble Predictive Analytics Resource), a novel framework combining chemical structure analysis with bioindicator data for holistic DILI prediction. The research utilized SMILES strings for 1,199 pharmaceutical compounds, analyzing topological fingerprints via the MACCS bit system and sourcing enzyme-compound interaction data through bioinformatics APIs. The predictive engine employs a diverse cohort of base learners, including deep neural architectures, gradient-boosted decision trees, Graph Neural Networks (GNNs), and Genetic Algorithms to process metabolic data. HEPAR identified a unique, understudied chemical bit significantly contributing to DILI, which was subsequently verified through hydrogen peroxide oxidation testing. An ensemble-based voting system demonstrated that combining base learners significantly improved performance over individual models. Metrics for Accuracy, MCC, and AUC-ROC consistently met or exceeded established hepatotoxicity benchmarks. HEPAR validates the effectiveness of bimodal analysis in toxicity prediction. By enabling preemptive DILI identification, this approach offers a pathway to accelerate drug development timelines while mitigating the public health risks associated with liver toxicity.
Awards (1)
- Third Award of $1,200 $1,200
Competition history
- ISEF 2026
Resources
Related projects
ISEF · 2021
Novel Prediction of Adverse Drug Reactions and Underlying Pathological Mechanisms via Hierarchical Classification
JSHS · 2023
A Microfluidic Liver Chip for Evaluating Idiosyncratic Drug-Induced Liver Injury
ISEF · 2023
A Novel Approach to Systemic in silico Drug Discovery Using a Machine Learning-Based Prediction of Binding Affinity
ISEF · 2022
Prediction of Genetic Predisposition to Isoniazid-Induced Hepatic Steatosis via Computational Analysis of Genetic Biomarkers
ISEF · 2024
Leveraging Deep Learning Models to Identify Structurally Adequate Drug Candidates for Parkinson's Disease
ISEF · 2023
HepaEase: Development of an Instigating Risk Assessment Tool and xLFIA Validating Potential Urinary Biomarkers for Early Detection of NAFLD
ISEF · 2022
PLCAI: Systematic Pipeline for Protein-Ligand Binding Prediction via Multi-Scale Convolution Neural Network With Applications in Interpretable Drug Design Process
ISEF · 2021
Application of Deep Learning in Target Identification Through Determining the Mechanism of Action Given Cellular Signature Data
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair